10-Q · 2026-11-16
Invivyd, Inc. shares its Q3 results, showcasing progress in biological product development amid industry competition.
| Name | Invivyd, Inc. |
|---|---|
| CIK | 0001832038 |
| Tickers | IVVD |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 2836 Biological Products, (No Diagnostic Substances) |
| EIN | 851403134 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | (781) 819-0080 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Invivyd, Inc. shares its Q3 results, showcasing progress in biological product development amid industry competition.
Invivyd, Inc. reveals its financial results, showcasing a strategic shift in operations and implications for the biological products industry.
452 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-463811 | 005-92804 | 261562671 | 34 | 10776 | |||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001012975-26-001059 | 005-92804 | 261560440 | 34 | 12085 | |||
| 2026-11-16 | 10-Q | 10-Q | 0001193125-26-462034 | 001-40703 | 261555373 | 34 | 11136512 | 1 | 1 | |
| 2026-11-16 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-462025 | 001-40703 | 261555365 | 34 | 1357632 | 1 | 1 |
| 2026-09-29 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-406007 | 001-40703 | 261419146 | 34 | 12765705 | 1 | 1 |
| 2026-09-02 | 4 | 4 | 0001193125-26-380337 | 5544 | ||||||
| 2026-09-02 | 3 | 3 | 0001193125-26-380335 | 17514 | ||||||
| 2026-09-01 | 4 | 4 | 0001193125-26-378862 | 23723 | ||||||
| 2026-09-01 | 8-K | 8-K | 5.02,8.01,9.01 | 0001193125-26-377493 | 001-40703 | 261348505 | 34 | 1477829 | 1 | 1 |
| 2026-08-18 | 4 | 4 | 0001193125-26-355915 | 11331 | ||||||
| 2026-08-18 | 4 | 4 | 0001193125-26-355914 | 11312 | ||||||
| 2026-08-18 | 4 | 4 | 0001193125-26-355913 | 11321 | ||||||
| 2026-08-18 | 4 | 4 | 0001193125-26-355912 | 11971 | ||||||
| 2026-08-18 | 4 | 4 | 0001193125-26-355911 | 11392 | ||||||
| 2026-08-17 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-354036 | 001-40703 | 261286699 | 33 | 4960 | |||
| 2026-08-17 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-354034 | 001-40703 | 261286696 | 33 | 4939 | |||
| 2026-08-17 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-354033 | 001-40703 | 261286695 | 33 | 4951 | |||
| 2026-08-17 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-354032 | 001-40703 | 261286693 | 33 | 4910 | |||
| 2026-08-17 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-354030 | 001-40703 | 261286686 | 33 | 4963 | |||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-352642 | 005-92804 | 261283746 | 34 | 10700 | |||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000921895-26-002171 | 005-92804 | 261281638 | 34 | 25646 | |||
| 2026-08-13 | 10-Q | 10-Q | 0001193125-26-349215 | 001-40703 | 261273538 | 34 | 10951840 | 1 | 1 | |
| 2026-08-13 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-349193 | 001-40703 | 261273447 | 34 | 1354513 | 1 | 1 |
| 2026-08-04 | 4 | 4 | 0001193125-26-332844 | 5768 | ||||||
| 2026-08-04 | 3 | 3 | 0001193125-26-332833 | 22028 | ||||||
| 2026-07-28 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-002467 | 005-92804 | 261212503 | 34 | 10845 | |||
| 2026-07-24 | 8-K | 8-K | 3.01 | 0001193125-26-316066 | 001-40703 | 261201510 | 34 | 176151 | 1 | 1 |
| 2026-07-06 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-295539 | 001-40703 | 261154241 | 34 | 1066795 | 1 | 1 |
| 2026-05-21 | 4 | 4 | 0001193125-26-234666 | 5447 | ||||||
| 2026-05-21 | 4 | 4 | 0001193125-26-234665 | 5451 | ||||||
| 2026-05-21 | 4 | 4 | 0001193125-26-234662 | 5558 | ||||||
| 2026-05-21 | 4 | 4 | 0001193125-26-234661 | 7983 | ||||||
| 2026-05-21 | 4 | 4 | 0001193125-26-234660 | 5467 | ||||||
| 2026-05-21 | 4 | 4 | 0001193125-26-234656 | 22313 | ||||||
| 2026-05-19 | 8-K | 8-K | 5.07 | 0001193125-26-230731 | 001-40703 | 26998589 | 34 | 193816 | 1 | 1 |
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001346824-26-000155 | 005-92804 | 26988992 | 34 | 14829 | |||
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-003489 | 005-92804 | 26988201 | 34 | 12214 | |||
| 2026-05-14 | S-8 | S-8 | 0001193125-26-223973 | 333-295885 | 26978747 | 33 | 404708 | 1 | 1 | |
| 2026-05-14 | 10-Q | 10-Q | 0001193125-26-222779 | 001-40703 | 26975821 | 34 | 8981829 | 1 | 1 | |
| 2026-05-14 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-26-222762 | 001-40703 | 26975810 | 34 | 8221340 | 1 | 1 |
| 2026-04-09 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-148865 | 001-40703 | 26849800 | 34 | 5921048 | 1 | 1 |
| 2026-04-06 | ARS | ARS | 0001193125-26-143853 | 001-40703 | 26841674 | 34 | 1068549 | |||
| 2026-04-06 | DEFA14A | DEFA14A | 0001193125-26-143812 | 001-40703 | 26841539 | 34 | 1197528 | |||
| 2026-04-06 | DEF 14A | DEF 14A | 0001193125-26-143783 | 001-40703 | 26841456 | 34 | 4863675 | 1 | 1 | |
| 2026-03-05 | 10-K | 10-K | 0001193125-26-092547 | 001-40703 | 26724189 | 34 | 15131438 | 1 | 1 | |
| 2026-03-05 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-26-092528 | 001-40703 | 26724180 | 34 | 7410542 | 1 | 1 |
| 2026-02-18 | 4 | 4 | 0001193125-26-057828 | 11240 | ||||||
| 2026-02-18 | 4 | 4 | 0001193125-26-057822 | 11224 | ||||||
| 2026-02-18 | 4 | 4 | 0001193125-26-057819 | 11230 | ||||||
| 2026-02-18 | 4 | 4 | 0001193125-26-057815 | 11442 | ||||||
| 2026-02-18 | 4 | 4 | 0001193125-26-057814 | 11883 | ||||||
| 2026-02-17 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-055377 | 001-40703 | 26644403 | 33 | 4982 | |||
| 2026-02-17 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-055370 | 001-40703 | 26644377 | 33 | 5006 | |||
| 2026-02-17 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-055365 | 001-40703 | 26644364 | 33 | 5003 | |||
| 2026-02-17 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-055356 | 001-40703 | 26644354 | 33 | 4994 | |||
| 2026-02-17 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-055348 | 001-40703 | 26644318 | 33 | 4955 | |||
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001346824-26-000045 | 005-92804 | 26642283 | 34 | 15545 | |||
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-26-001128 | 005-92804 | 26641991 | 34 | 12428 | |||
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000921895-26-000469 | 005-92804 | 26641721 | 34 | 25337 | |||
| 2026-02-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001012975-26-000135 | 005-92804 | 26632835 | 34 | 11842 | |||
| 2026-02-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001213900-26-015651 | 005-92804 | 26627407 | 34 | 29818 | |||
| 2026-01-30 | 4 | 4 | 0001193125-26-031858 | 5453 | ||||||
| 2026-01-30 | 4 | 4 | 0001193125-26-031856 | 5447 | ||||||
| 2026-01-30 | 4 | 4 | 0001193125-26-031840 | 5463 | ||||||
| 2026-01-30 | 4 | 4 | 0001193125-26-031822 | 5419 | ||||||
| 2026-01-30 | 4 | 4 | 0001193125-26-031819 | 5466 | ||||||
| 2026-01-08 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-26-006997 | 001-40703 | 26517350 | 34 | 13776091 | 1 | 1 |
| 2025-12-29 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001193125-25-335350 | 005-92804 | 251609322 | 34 | 8178 | |||
| 2025-12-23 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-003900 | 333-290685 | 251602316 | 33 | 1809 | ||
| 2025-12-23 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-010678 | 001-40703 | 251600895 | 33 | 5697 | |||
| 2025-12-23 | 8-K | 8-K | 8.01,9.01 | 0001193125-25-329488 | 001-40703 | 251594686 | 34 | 319262 | 1 | 1 |
| 2025-12-19 | CORRESP | filename1.htm | 0001193125-25-327185 | 6202 | ||||||
| 2025-12-19 | S-3/A | S-3/A | 0001193125-25-327055 | 333-290685 | 251588454 | 33 | 310552 | 1 | 1 | |
| 2025-11-25 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001193125-25-297003 | 005-92804 | 251520776 | 34 | 233346 | |||
| 2025-11-24 | 8-K | 8-K | 8.01,9.01 | 0001193125-25-291992 | 001-40703 | 251509558 | 34 | 323160 | 1 | 1 |
| 2025-11-20 | 4 | 4 | 0001193125-25-289825 | 4551 | ||||||
| 2025-11-19 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-25-288347 | 001-40703 | 251500281 | 34 | 1381866 | 1 | 1 |
| 2025-11-19 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001193125-25-288171 | 005-92804 | 251499720 | 34 | 135773 | |||
| 2025-11-19 | 424B5 | 424B5 | 0001193125-25-286661 | 333-267643 | 251496460 | 33 | 772945 | 1 | 1 | |
| 2025-11-17 | FWP | FWP | 0001193125-25-284712 | 333-267643 | 251491543 | 34 | 120235 | |||
| 2025-11-17 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-008974 | 001-40703 | 251491500 | 33 | 4952 | |||
| 2025-11-17 | 424B5 | 424B5 | 0001193125-25-284616 | 333-267643 | 251491139 | 33 | 622125 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-004982 | 005-92804 | 251485550 | 34 | 12874 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001274173-25-000285 | 005-92804 | 251483160 | 34 | 10739 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-004828 | 005-92804 | 251481398 | 34 | 11277 | |||
| 2025-11-12 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001193125-25-277894 | 005-92804 | 251474036 | 34 | 17475 | |||
| 2025-11-07 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001193125-25-272648 | 005-92804 | 251463808 | 34 | 31611 | |||
| 2025-11-06 | 10-Q | 10-Q | 0001193125-25-268076 | 001-40703 | 251456136 | 34 | 9924289 | 1 | 1 | |
| 2025-11-06 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-25-268057 | 001-40703 | 251456115 | 34 | 9438408 | 1 | 1 |
| 2025-10-30 | 8-K | 8-K | 8.01,9.01 | 0001193125-25-258526 | 001-40703 | 251435545 | 34 | 11387652 | 1 | 1 |
| 2025-10-22 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000921895-25-002791 | 005-92804 | 251411165 | 34 | 38504 | |||
| 2025-10-14 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001213900-25-098418 | 005-92804 | 251389988 | 34 | 47457 | |||
| 2025-10-06 | 8-K | 8-K | 8.01,9.01 | 0001193125-25-230898 | 001-40703 | 251375591 | 34 | 326875 | 1 | 1 |
| 2025-10-02 | S-3 | S-3 | 0001193125-25-228321 | 333-290685 | 251369097 | 33 | 1229653 | 1 | 1 | |
| 2025-09-24 | 4 | 4 | 0001193125-25-215634 | 5470 | ||||||
| 2025-09-24 | 3 | 3 | 0001193125-25-215619 | 21098 | ||||||
| 2025-09-24 | 8-K | 8-K | 5.02,7.01,8.01,9.01 | 0001193125-25-215541 | 001-40703 | 251339041 | 34 | 321311 | 1 | 1 |
| 2025-09-08 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001274173-25-000255 | 005-92804 | 251299381 | 34 | 9501 | |||
| 2025-08-29 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-023305 | 005-92804 | 251281426 | 34 | 19666 | |||
| 2025-08-27 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-003863 | 005-92804 | 251265456 | 34 | 17942 | |||
| 2025-08-26 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000902664-25-003854 | 005-92804 | 251257771 | 34 | 10294 | |||
| 2025-08-22 | 8-K | 8-K | 1.01,8.01,9.01 | 0000950170-25-110952 | 001-40703 | 251246314 | 34 | 1534334 | 1 | 1 |
| 2025-08-22 | 424B5 | 424B5 | 0001193125-25-185639 | 333-267643 | 251242132 | 33 | 758405 | 1 | 1 | |
| 2025-08-20 | FWP | FWP | 0001193125-25-184081 | 333-267643 | 251236893 | 34 | 83022 | |||
| 2025-08-20 | 424B5 | 424B5 | 0001193125-25-184075 | 333-267643 | 251236853 | 33 | 611923 | |||
| 2025-08-19 | 4 | 4 | 0000950170-25-110346 | 30695 | ||||||
| 2025-08-19 | 4 | 4 | 0000950170-25-110344 | 31808 | ||||||
| 2025-08-19 | 4 | 4 | 0000950170-25-110343 | 31692 | ||||||
| 2025-08-19 | 4 | 4 | 0000950170-25-110341 | 31834 | ||||||
| 2025-08-19 | 4 | 4 | 0000950170-25-110339 | 31182 | ||||||
| 2025-08-18 | 144 | xsl144X01/primary_doc.xml | 0001123292-25-000376 | 001-40703 | 251229252 | 33 | 19262 | |||
| 2025-08-18 | 144 | xsl144X01/primary_doc.xml | 0001123292-25-000374 | 001-40703 | 251229251 | 33 | 20995 | |||
| 2025-08-18 | 144 | xsl144X01/primary_doc.xml | 0001123292-25-000372 | 001-40703 | 251229247 | 33 | 19275 | |||
| 2025-08-18 | 144 | xsl144X01/primary_doc.xml | 0001123292-25-000370 | 001-40703 | 251229244 | 33 | 19102 | |||
| 2025-08-18 | 144 | xsl144X01/primary_doc.xml | 0001123292-25-000368 | 001-40703 | 251229236 | 33 | 19380 | |||
| 2025-08-14 | 10-Q | 10-Q | 0000950170-25-109029 | 001-40703 | 251220667 | 34 | 9473381 | 1 | 1 | |
| 2025-08-14 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-25-180890 | 001-40703 | 251220584 | 34 | 10174699 | 1 | 1 |
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001641172-25-023725 | 005-92804 | 251214432 | 34 | 11824 | |||
| 2025-07-02 | 8-K | 8-K | 8.01,9.01 | 0000950170-25-092528 | 001-40703 | 251098322 | 34 | 342275 | 1 | 1 |
| 2025-06-26 | 8-K | 8-K | 8.01,9.01 | 0000950170-25-090172 | 001-40703 | 251075049 | 34 | 352220 | 1 | 1 |
| 2025-05-22 | 4 | 4 | 0000950170-25-076343 | 5473 | ||||||
| 2025-05-22 | 4 | 4 | 0000950170-25-076337 | 5415 | ||||||
| 2025-05-22 | 4 | 4 | 0000950170-25-076332 | 5406 | ||||||
| 2025-05-22 | 4 | 4 | 0000950170-25-076323 | 7834 | ||||||
| 2025-05-22 | 4 | 4 | 0000950170-25-076316 | 5393 | ||||||
| 2025-05-22 | 4 | 4 | 0000950170-25-076305 | 5359 | ||||||
| 2025-05-20 | 8-K | 8-K | 5.07 | 0000950170-25-075199 | 001-40703 | 25969011 | 34 | 196193 | 1 | 1 |
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-001965 | 005-92804 | 25948985 | 34 | 11381 | |||
| 2025-05-15 | 10-Q | 10-Q | 0000950170-25-071974 | 001-40703 | 25948681 | 34 | 8073162 | 1 | 1 | |
| 2025-05-15 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-25-120261 | 001-40703 | 25948646 | 34 | 15276187 | 1 | 1 |
| 2025-05-12 | 8-K | 8-K | 8.01,9.01 | 0000950170-25-068543 | 001-40703 | 25932552 | 34 | 331325 | 1 | 1 |
| 2025-04-25 | 8-K | 8-K | 3.01 | 0000950170-25-058705 | 001-40703 | 25873935 | 34 | 180496 | 1 | 1 |
| 2025-04-21 | 8-K | 8-K | 1.01,2.03,7.01,9.01 | 0000950170-25-056005 | 001-40703 | 25851291 | 34 | 1289004 | 1 | 1 |
| 2025-04-07 | ARS | ARS | 0000950170-25-051619 | 001-40703 | 25818482 | 34 | 1023397 | |||
| 2025-04-07 | DEFA14A | DEFA14A | 0000950170-25-051610 | 001-40703 | 25818411 | 34 | 1608413 | |||
| 2025-04-07 | DEF 14A | DEF 14A | 0000950170-25-051587 | 001-40703 | 25818243 | 34 | 3807396 | 1 | 1 | |
| 2025-03-26 | 4 | 4 | 0000950170-25-045465 | 5497 | ||||||
| 2025-03-26 | 3 | 3 | 0000950170-25-045455 | 17298 | ||||||
| 2025-03-26 | 8-K | 8-K | 5.02,7.01,9.01 | 0000950170-25-045302 | 001-40703 | 25773696 | 34 | 327230 | 1 | 1 |
| 2025-03-20 | 10-K | 10-K | 0000950170-25-042332 | 001-40703 | 25754572 | 34 | 12962155 | 1 | 1 | |
| 2025-03-20 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-042331 | 001-40703 | 25754555 | 34 | 541350 | 1 | 1 |
| 2025-03-05 | 8-K | 8-K | 8.01,9.01 | 0000950170-25-033068 | 001-40703 | 25708808 | 34 | 335067 | 1 | 1 |
| 2025-02-24 | 8-K | 8-K | 8.01,9.01 | 0000950170-25-025227 | 001-40703 | 25654180 | 34 | 341971 | 1 | 1 |
| 2025-02-19 | 4 | 4 | 0000950170-25-023245 | 8102 | ||||||
| 2025-02-19 | 4 | 4 | 0000950170-25-023241 | 8150 | ||||||
| 2025-02-19 | 4 | 4 | 0000950170-25-023239 | 8164 | ||||||
| 2025-02-19 | 4 | 4 | 0000950170-25-023238 | 8131 | ||||||
| 2025-02-19 | 4 | 4 | 0000950170-25-023232 | 8147 | ||||||
| 2025-02-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-25-000768 | 005-92804 | 25612389 | 34 | 11459 | |||
| 2025-02-03 | 8-K | 8-K | 2.02,8.01,9.01 | 0000950170-25-012018 | 001-40703 | 25580580 | 34 | 1723528 | 1 | 1 |
| 2025-01-27 | 8-K | 8-K | 8.01,9.01 | 0000950170-25-008995 | 001-40703 | 25555755 | 34 | 338577 | 1 | 1 |
| 2025-01-10 | 8-K | 8-K | 8.01,9.01 | 0000950170-25-003781 | 001-40703 | 25520370 | 34 | 335507 | 1 | 1 |
| 2024-12-31 | 4 | 4 | 0000950170-24-141701 | 18802 | ||||||
| 2024-12-27 | 8-K | 8-K | 3.01 | 0000950170-24-140800 | 001-40703 | 241585863 | 34 | 177169 | 1 | 1 |
| 2024-12-26 | 4 | 4 | 0000950170-24-140613 | 20890 | ||||||
| 2024-12-20 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-010012 | 001-40703 | 241568580 | 33 | 11131 | |||
| 2024-12-19 | 4 | 4 | 0000950170-24-138597 | 18800 | ||||||
| 2024-12-16 | 4 | 4 | 0000950170-24-136858 | 16715 | ||||||
| 2024-12-12 | SC 13D/A | SC 13D/A | 0001193125-24-277124 | 005-92804 | 241545416 | 34 | 198107 | |||
| 2024-12-11 | 4 | 4 | 0000950170-24-135509 | 18804 | ||||||
| 2024-12-09 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-009555 | 001-40703 | 241535434 | 33 | 5085 | |||
| 2024-12-02 | 8-K | 8-K | 5.02 | 0000950170-24-132158 | 001-40703 | 241518615 | 34 | 167384 | 1 | 1 |
| 2024-11-14 | SC 13G/A | SC 13G/A | 0001193125-24-258666 | 005-92804 | 241463169 | 34 | 66409 | |||
| 2024-11-14 | SC 13G/A | deeptrack-ivvd093024a1.htm | 0001172661-24-004731 | 005-92804 | 241457687 | 34 | 103260 | |||
| 2024-11-14 | 10-Q | 10-Q | 0000950170-24-126735 | 001-40703 | 241457177 | 34 | 7908798 | 1 | 1 | |
| 2024-11-14 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-24-257993 | 001-40703 | 241457170 | 34 | 7250824 | 1 | 1 |
| 2024-11-12 | SC 13G/A | filing.txt | 0000315066-24-002844 | 005-92804 | 241444873 | 34 | 8099 | |||
| 2024-11-08 | SC 13G/A | SC 13G/A | 0001104659-24-115886 | 005-92804 | 241440869 | 34 | 246499 | |||
| 2024-10-29 | 8-K | 8-K | 2.02,8.01,9.01 | 0000950170-24-117934 | 001-40703 | 241402678 | 34 | 362190 | 1 | 1 |
| 2024-09-23 | 8-K | 8-K | 8.01,9.01 | 0000950170-24-108624 | 001-40703 | 241314615 | 34 | 10239665 | 1 | 1 |
| 2024-09-06 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-214779 | 001-40703 | 241283076 | 34 | 6921038 | 1 | 1 |
| 2024-09-04 | 8-K | 8-K | 8.01,9.01 | 0000950170-24-103100 | 001-40703 | 241275850 | 34 | 228742 | 1 | 1 |
| 2024-09-03 | 8-K | 8-K | 8.01,9.01 | 0000950170-24-102552 | 001-40703 | 241271886 | 34 | 237333 | 1 | 1 |
| 2024-08-27 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-207466 | 001-40703 | 241243447 | 34 | 6539433 | 1 | 1 |
| 2024-08-14 | 10-Q | 10-Q | 0000950170-24-096674 | 001-40703 | 241204325 | 34 | 8100852 | 1 | 1 | |
| 2024-08-14 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-24-200256 | 001-40703 | 241204316 | 34 | 10837893 | 1 | 1 |
| 2024-06-14 | 8-K | 8-K | 8.01,9.01 | 0000950170-24-073322 | 001-40703 | 241043131 | 34 | 319130 | 1 | 1 |
| 2024-06-06 | 4 | 4 | 0000950170-24-069965 | 5672 | ||||||
| 2024-06-06 | 3 | 3 | 0000950170-24-069959 | 13115 | ||||||
| 2024-05-31 | 4 | 4 | 0000950170-24-067438 | 14354 | ||||||
| 2024-05-31 | 8-K | 8-K | 5.02,8.01,9.01 | 0001193125-24-151007 | 001-40703 | 241007668 | 34 | 228128 | 1 | 1 |
| 2024-05-29 | 144 | xsl144X01/primary_doc.xml | 0001963745-24-000026 | 001-40703 | 24999839 | 33 | 4649 | |||
| 2024-05-23 | 4 | 4 | 0000950170-24-064152 | 5481 | ||||||
| 2024-05-23 | 4 | 4 | 0000950170-24-064146 | 5374 | ||||||
| 2024-05-23 | 4 | 4 | 0000950170-24-064138 | 5545 | ||||||
| 2024-05-23 | 4 | 4 | 0000950170-24-064126 | 5423 | ||||||
| 2024-05-23 | 4 | 4 | 0000950170-24-064113 | 7845 | ||||||
| 2024-05-23 | 4 | 4 | 0000950170-24-064071 | 5401 | ||||||
| 2024-05-23 | 3 | 3 | 0000950170-24-064026 | 14384 | ||||||
| 2024-05-23 | 4 | 4 | 0000950170-24-064007 | 5511 | ||||||
| 2024-05-23 | 3 | 3 | 0000950170-24-064003 | 14346 | ||||||
| 2024-05-22 | 8-K | 8-K | 5.07,7.01,9.01 | 0000950170-24-063279 | 001-40703 | 24971630 | 34 | 346485 | 1 | 1 |
| 2024-05-16 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-003783 | 001-40703 | 24955657 | 33 | 4818 | |||
| 2024-05-09 | S-8 | S-8 | 0000950170-24-057117 | 333-279268 | 24931289 | 33 | 201177 | |||
| 2024-05-09 | 10-Q | 10-Q | 0000950170-24-057017 | 001-40703 | 24931034 | 34 | 6217875 | 1 | 1 | |
| 2024-05-09 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-24-135260 | 001-40703 | 24930560 | 34 | 11255779 | 1 | 1 |
| 2024-05-07 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-132585 | 001-40703 | 24919642 | 34 | 200137 | 1 | 1 |
| 2024-04-19 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-04-19 16:00:00 | 9999999995-24-001044 | 333-276986 | 24859415 | 33 | 1857 | ||
| 2024-04-18 | ARS | ARS | 0000950170-24-045570 | 001-40703 | 24854482 | 34 | 956791 | |||
| 2024-04-18 | CORRESP | filename1.htm | 0000950170-24-045558 | 11739 | ||||||
| 2024-04-18 | DEF 14A | DEF 14A | 0000950170-24-045549 | 001-40703 | 24854354 | 34 | 2134232 | |||
| 2024-04-12 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-24-093929 | 001-40703 | 24839995 | 34 | 204621 | 1 | 1 |
| 2024-04-04 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-087408 | 001-40703 | 24824089 | 34 | 4285401 | 1 | 1 |
| 2024-03-28 | 10-K | 10-K | 0000950170-24-037610 | 001-40703 | 24793481 | 34 | 12096930 | 1 | 1 | |
| 2024-03-28 | 8-K | 8-K | 2.02,9.01 | 0001193125-24-079597 | 001-40703 | 24793458 | 34 | 278512 | 1 | 1 |
| 2024-03-25 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-24-075582 | 001-40703 | 24776704 | 34 | 11538284 | 1 | 1 |
| 2024-02-23 | UPLOAD | filename1.pdf | 0000000000-24-002075 | 333-276986 | 40345 | |||||
| 2024-02-14 | SC 13G | SC 13G | 0001193125-24-036575 | 005-92804 | 24640483 | 34 | 79556 | |||
| 2024-02-12 | SC 13G | deeptrack-ivvd020224.htm | 0001172661-24-000706 | 005-92804 | 24619758 | 34 | 103112 | |||
| 2024-02-09 | S-3 | S-3 | 0001193125-24-030154 | 333-276986 | 24615737 | 33 | 375601 | |||
| 2024-02-09 | 8-K | 8-K | 5.02,8.01,9.01 | 0000950170-24-013243 | 001-40703 | 24614638 | 34 | 8624012 | 1 | 1 |
| 2024-02-09 | SC 13G/A | filing.txt | 0000315066-24-001257 | 005-92804 | 24611767 | 34 | 8126 | |||
| 2024-01-26 | 4 | 4 | 0000950170-24-007981 | 5495 | ||||||
| 2024-01-26 | 3 | 3 | 0000950170-24-007972 | 18463 | ||||||
| 2024-01-22 | 4 | 4 | 0000950170-24-006070 | 4544 | ||||||
| 2024-01-22 | SC 13D/A | SC 13D/A | 0001193125-24-012170 | 005-92804 | 24549020 | 34 | 33892 | |||
| 2024-01-19 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-000381 | 001-40703 | 24545912 | 33 | 5009 | |||
| 2024-01-08 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-003875 | 001-40703 | 24518318 | 34 | 9180049 | 1 | 1 |
| 2024-01-03 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-001013 | 001-40703 | 24504335 | 34 | 186384 | 1 | 1 |
| 2023-12-22 | 8-K | 8-K | 1.01,9.01 | 0001193125-23-302195 | 001-40703 | 231510549 | 34 | 420730 | 1 | 1 |
| 2023-12-22 | 424B5 | 424B5 | 0001193125-23-302190 | 333-267643 | 231510533 | 33 | 525436 | |||
| 2023-12-20 | 4 | 4 | 0000950170-23-071919 | 5490 | ||||||
| 2023-12-20 | 4 | 4 | 0000950170-23-071918 | 5492 | ||||||
| 2023-12-20 | 4 | 4 | 0000950170-23-071915 | 5495 | ||||||
| 2023-12-20 | 4 | 4 | 0000950170-23-071914 | 5501 | ||||||
| 2023-12-20 | 4 | 4 | 0000950170-23-071909 | 5468 | ||||||
| 2023-12-20 | 4 | 4 | 0000950170-23-071907 | 5532 | ||||||
| 2023-12-20 | 4 | 4 | 0000950170-23-071905 | 5517 | ||||||
| 2023-12-18 | 8-K | FORM 8-K | 8.01,9.01 | 0001193125-23-297099 | 001-40703 | 231492237 | 34 | 183539 | 1 | 1 |
| 2023-11-20 | 4 | 4 | 0000950170-23-065108 | 5553 | ||||||
| 2023-11-09 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-23-274506 | 001-40703 | 231392498 | 34 | 5424400 | 1 | 1 |
| 2023-11-09 | 10-Q | 10-Q | 0000950170-23-062043 | 001-40703 | 231392478 | 34 | 9472900 | 1 | 1 | |
| 2023-09-11 | SC 13G/A | filing.txt | 0000315066-23-002573 | 005-92804 | 231246761 | 34 | 8018 | |||
| 2023-09-11 | 8-K | 8-K | 8.01,9.01 | 0001193125-23-231961 | 001-40703 | 231246677 | 34 | 10337462 | 1 | 1 |
| 2023-09-05 | 4 | 4 | 0000950170-23-046430 | 5612 | ||||||
| 2023-09-05 | 3 | 3 | 0000950170-23-046412 | 14636 | ||||||
| 2023-09-05 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-23-228074 | 001-40703 | 231234116 | 34 | 350531 | 1 | 1 |
| 2023-08-10 | 10-Q | 10-Q | 0000950170-23-041352 | 001-40703 | 231159743 | 34 | 9503514 | 1 | 1 | |
| 2023-08-10 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-209020 | 001-40703 | 231159209 | 34 | 248758 | 1 | 1 |
| 2023-07-27 | 4 | 4 | 0000950170-23-035191 | 5430 | ||||||
| 2023-07-27 | 3 | 3 | 0000950170-23-035177 | 8583 | ||||||
| 2023-07-27 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-23-196086 | 001-40703 | 231118434 | 34 | 174631 | 1 | 1 |
| 2023-06-29 | 8-K | 8-K | 8.01,9.01 | 0001193125-23-177996 | 001-40703 | 231054279 | 34 | 9911207 | 1 | 1 |
| 2023-05-25 | 4 | FORM 4 SUBMISSION | 0000899243-23-013935 | 10707 | ||||||
| 2023-05-25 | 4 | FORM 4 SUBMISSION | 0000899243-23-013920 | 10648 | ||||||
| 2023-05-25 | 4 | FORM 4 SUBMISSION | 0000899243-23-013918 | 10631 | ||||||
| 2023-05-25 | 4 | FORM 4 SUBMISSION | 0000899243-23-013917 | 5549 | ||||||
| 2023-05-25 | 4 | FORM 4 SUBMISSION | 0000899243-23-013916 | 5534 | ||||||
| 2023-05-25 | 4 | FORM 4 SUBMISSION | 0000899243-23-013913 | 5569 | ||||||
| 2023-05-25 | 4 | FORM 4 SUBMISSION | 0000899243-23-013912 | 7916 | ||||||
| 2023-05-25 | 8-K | 8-K | 5.03,5.07,9.01 | 0001193125-23-154233 | 001-40703 | 23960922 | 34 | 185939 | 1 | 1 |
| 2023-05-11 | 10-Q | 10-Q | 0000950170-23-021235 | 001-40703 | 23911122 | 34 | 8626357 | 1 | 1 | |
| 2023-05-11 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-142010 | 001-40703 | 23911017 | 34 | 235679 | 1 | 1 |
| 2023-05-02 | 8-K | 8-K | 5.02,8.01,9.01 | 0001193125-23-131287 | 001-40703 | 23876630 | 34 | 8774555 | 1 | 1 |
| 2023-04-12 | 4 | FORM 4 SUBMISSION | 0000899243-23-011197 | 5826 | ||||||
| 2023-04-12 | 3 | FORM 3 SUBMISSION | 0000899243-23-011195 | 7703 | ||||||
| 2023-04-10 | ARS | ARS | 0000950170-23-012300 | 001-40703 | 23811359 | 34 | 2533846 | |||
| 2023-04-10 | DEFA14A | DEFA14A | 0001193125-23-096532 | 001-40703 | 23811251 | 34 | 120329 | |||
| 2023-04-10 | DEF 14A | DEF 14A | 0001193125-23-096524 | 001-40703 | 23811223 | 34 | 734585 | |||
| 2023-03-31 | PRE 14A | PRE 14A | 0001193125-23-088183 | 001-40703 | 23788465 | 34 | 491559 | |||
| 2023-03-28 | 4 | FORM 4 SUBMISSION | 0000899243-23-009798 | 5808 | ||||||
| 2023-03-28 | 3 | FORM 3 SUBMISSION | 0000899243-23-009795 | 7672 | ||||||
| 2023-03-23 | 10-K | 10-K | 0000950170-23-009516 | 001-40703 | 23756632 | 34 | 14862400 | 1 | 1 | |
| 2023-03-23 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-077876 | 001-40703 | 23756337 | 34 | 238764 | 1 | 1 |
| 2023-03-06 | 8-K | 8-K | 8.01,9.01 | 0001193125-23-060699 | 001-40703 | 23707581 | 34 | 6911656 | 1 | 1 |
| 2023-02-09 | SC 13G/A | filing.txt | 0000315066-23-001757 | 005-92804 | 23603099 | 34 | 8218 | |||
| 2023-01-09 | 8-K | FORM 8-K | 8.01,9.01 | 0001193125-23-004133 | 001-40703 | 23516537 | 34 | 5952398 | 1 | 1 |
| 2022-12-16 | 4 | FORM 4 SUBMISSION | 0000899243-22-038853 | 10283 | ||||||
| 2022-12-16 | 4 | FORM 4 SUBMISSION | 0000899243-22-038851 | 5582 | ||||||
| 2022-12-16 | 4 | FORM 4 SUBMISSION | 0000899243-22-038849 | 5609 | ||||||
| 2022-12-16 | 4 | FORM 4 SUBMISSION | 0000899243-22-038845 | 5768 | ||||||
| 2022-12-16 | 3 | FORM 3 SUBMISSION | 0000899243-22-038844 | 7688 | ||||||
| 2022-12-16 | 4 | FORM 4 SUBMISSION | 0000899243-22-038843 | 8516 | ||||||
| 2022-12-06 | 4 | FORM 4 SUBMISSION | 0000899243-22-037804 | 5607 | ||||||
| 2022-12-06 | 3 | FORM 3 SUBMISSION | 0000899243-22-037803 | 11056 | ||||||
| 2022-12-06 | 8-K | FORM 8-K | 5.02,8.01,9.01 | 0001193125-22-299428 | 001-40703 | 221448106 | 34 | 358301 | 1 | 1 |
| 2022-11-29 | D | xslFormDX01/primary_doc.xml | 06b | 0001567619-22-021016 | 021-466075 | 221433610 | 33 | 15059 | ||
| 2022-11-17 | 8-K | 8-K | 1.01,3.02,8.01,9.01 | 0001193125-22-287208 | 001-40703 | 221396822 | 34 | 190668 | 1 | 1 |
| 2022-11-10 | 10-Q | 10-Q | 0000950170-22-024516 | 001-40703 | 221377692 | 34 | 13131594 | 1 | 1 | |
| 2022-11-10 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-282613 | 001-40703 | 221377325 | 34 | 244686 | 1 | 1 |
| 2022-11-04 | 4 | FORM 4 SUBMISSION | 0000899243-22-035198 | 5496 | ||||||
| 2022-10-24 | 4 | FORM 4 SUBMISSION | 0000899243-22-034029 | 5630 | ||||||
| 2022-10-24 | 3 | FORM 3 SUBMISSION | 0000899243-22-034028 | 7600 | ||||||
| 2022-10-24 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-22-267606 | 001-40703 | 221326312 | 34 | 174541 | 1 | 1 |
| 2022-10-13 | 3 | FORM 3 SUBMISSION | 0000899243-22-033561 | 7640 | ||||||
| 2022-10-13 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-22-262167 | 001-40703 | 221309240 | 34 | 331175 | 1 | 1 |
| 2022-10-05 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2022-10-05 16:00:00 | 9999999995-22-002946 | 333-267643 | 221297028 | 33 | 1809 | ||
| 2022-10-03 | CORRESP | filename1.htm | 0001193125-22-256380 | 6344 | ||||||
| 2022-09-30 | UPLOAD | filename1.pdf | 0000000000-22-010798 | 40251 | ||||||
| 2022-09-28 | S-3 | S-3 | 0001193125-22-253372 | 333-267643 | 221276888 | 33 | 818202 | |||
| 2022-09-13 | 8-K | 8-K | 5.03,9.01 | 0001193125-22-243285 | 001-40703 | 221239737 | 34 | 307146 | 1 | 1 |
| 2022-09-12 | 8-K | 8-K | 8.01,9.01 | 0001193125-22-242433 | 001-40703 | 221237388 | 34 | 13428364 | 1 | 1 |
| 2022-09-01 | 4 | FORM 4 SUBMISSION | 0000899243-22-030183 | 4977 | ||||||
| 2022-08-19 | SC 13D/A | ADAGIO THERAPEUTICS, INC. | 0000902664-22-004064 | 005-92804 | 221181631 | 34 | 57234 | |||
| 2022-08-19 | 4 | FORM 4 SUBMISSION | 0000899243-22-029295 | 11409 | ||||||
| 2022-08-15 | 10-Q | 10-Q | 0000950170-22-017242 | 001-40703 | 221162454 | 34 | 9912327 | 1 | 1 | |
| 2022-08-15 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-220559 | 001-40703 | 221162314 | 34 | 252515 | 1 | 1 |
| 2022-07-06 | 4 | FORM 4 SUBMISSION | 0000899243-22-025328 | 9484 | ||||||
| 2022-07-05 | 8-K | 8-K | 5.02,8.01,9.01 | 0001193125-22-187977 | 001-40703 | 221065726 | 34 | 382740 | 1 | 1 |
| 2022-07-05 | SC 13D/A | SC 13D/A | 0001193125-22-187564 | 005-92804 | 221063233 | 34 | 105647 | |||
| 2022-06-30 | 8-K | 8-K | 5.02 | 0001193125-22-186218 | 001-40703 | 221058397 | 34 | 146862 | 1 | 1 |
| 2022-06-24 | SC 13D/A | SC 13D/A | 0001193125-22-181642 | 005-92804 | 221040882 | 34 | 98831 | |||
| 2022-06-24 | SC 13D/A | SCHEDULE 13D (AMENDMENT NO. 2) | 0000914121-22-004040 | 005-92804 | 221040868 | 34 | 101303 | |||
| 2022-06-24 | 4 | FORM 4 SUBMISSION | 0000899243-22-024047 | 10171 | ||||||
| 2022-06-24 | SC 13D/A | SC 13D/A | 0001193125-22-181609 | 005-92804 | 221040769 | 34 | 30082 | |||
| 2022-06-24 | SC 13D/A | SC 13D/A | 0001193125-22-181596 | 005-92804 | 221040708 | 34 | 200974 | |||
| 2022-06-24 | 4 | FORM 4 SUBMISSION | 0000899243-22-024027 | 5560 | ||||||
| 2022-06-24 | 4 | FORM 4 SUBMISSION | 0000899243-22-024021 | 12404 | ||||||
| 2022-06-24 | 3 | FORM 3 SUBMISSION | 0000899243-22-024018 | 7601 | ||||||
| 2022-06-24 | 4 | FORM 4 SUBMISSION | 0000899243-22-024015 | 5438 | ||||||
| 2022-06-24 | 4 | FORM 4 SUBMISSION | 0000899243-22-024012 | 5427 | ||||||
| 2022-06-24 | 4 | FORM 4 SUBMISSION | 0000899243-22-023996 | 5407 | ||||||
| 2022-06-24 | 4 | FORM 4 SUBMISSION | 0000899243-22-023984 | 5446 | ||||||
| 2022-06-24 | 4 | FORM 4 SUBMISSION | 0000899243-22-023969 | 5506 | ||||||
| 2022-06-24 | SC 13D/A | ADAGIO THERAPEUTICS, INC. | 0000902664-22-003399 | 005-92804 | 221040284 | 34 | 51597 | |||
| 2022-06-22 | 8-K | 8-K | 5.07 | 0001193125-22-178882 | 001-40703 | 221032915 | 34 | 164734 | 1 | 1 |
| 2022-06-21 | DEFA14C | DEFA14C | 0001193125-22-177782 | 001-40703 | 221029104 | 34 | 9635 | |||
| 2022-06-21 | 8-K | 8-K | 5.02 | 0001193125-22-177777 | 001-40703 | 221029080 | 34 | 147837 | 1 | 1 |
| 2022-06-06 | DFAN14A | DFAN14A | 0001193125-22-167561 | 001-40703 | 22996589 | 34 | 620379 | |||
| 2022-06-02 | DEFC14C | DEFC14C | 0001193125-22-166247 | 001-40703 | 22991131 | 34 | 426302 | |||
| 2022-05-31 | CORRESP | filename1.htm | 0001193125-22-164093 | 22209 | ||||||
| 2022-05-31 | PRER14C | PRER14C | 0001193125-22-164089 | 001-40703 | 22984514 | 34 | 398281 | |||
| 2022-05-27 | UPLOAD | filename1.pdf | 0000000000-22-005843 | 44395 | ||||||
| 2022-05-19 | DEFA14C | DEFA14C | 0001193125-22-155177 | 001-40703 | 22944240 | 34 | 11028 | |||
| 2022-05-19 | 8-K | 8-K | 8.01 | 0001193125-22-155156 | 001-40703 | 22944122 | 34 | 149838 | 1 | 1 |
| 2022-05-19 | PREC14C | PREC14C | 0001193125-22-155139 | 001-40703 | 22944030 | 34 | 397450 | |||
| 2022-05-13 | S-8 | S-8 | 0001193125-22-149581 | 333-264920 | 22920827 | 33 | 82802 | |||
| 2022-05-13 | 10-Q | 10-Q | 0000950170-22-009799 | 001-40703 | 22920298 | 34 | 8546031 | 1 | 1 | |
| 2022-05-13 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-149345 | 001-40703 | 22920206 | 34 | 233606 | 1 | 1 |
| 2022-04-29 | 10-K/A | 10-K/A | 0001193125-22-134035 | 001-40703 | 22876502 | 34 | 773655 | 1 | 1 | |
| 2022-04-29 | DEFC14A | DEFC14A | 0001193125-22-133527 | 001-40703 | 22875068 | 34 | 953488 | |||
| 2022-04-27 | PRRN14A | PRRN14A | 0001193125-22-122799 | 001-40703 | 22858410 | 34 | 899946 | |||
| 2022-04-26 | SC 13D/A | ADAGIO THERAPEUTICS, INC. | 0000902664-22-002675 | 005-92804 | 22852581 | 34 | 51929 | |||
| 2022-04-26 | PREC14A | PREC14A | 0001193125-22-118162 | 001-40703 | 22851910 | 34 | 1229155 | |||
| 2022-04-26 | SC 13D/A | SCHEDULE 13D (AMENDMENT NO. 1) | 0000914121-22-003216 | 005-92804 | 22851589 | 34 | 117316 | |||
| 2022-04-26 | SC 13D/A | SC 13D/A | 0001193125-22-118343 | 005-92804 | 22851565 | 34 | 209439 | |||
| 2022-04-26 | SC 13D/A | SC 13D/A | 0001193125-22-118329 | 005-92804 | 22851547 | 34 | 104772 | |||
| 2022-04-26 | SC 13D/A | SC 13D/A | 0001193125-22-118250 | 005-92804 | 22851367 | 34 | 38807 | |||
| 2022-04-25 | PRRN14A | PRRN14A | 0001193125-22-117915 | 001-40703 | 22850836 | 34 | 956437 | |||
| 2022-04-18 | UPLOAD | filename1.pdf | 0000000000-22-004153 | 49015 | ||||||
| 2022-04-11 | PREC14A | PREC14A | 0001193125-22-100921 | 001-40703 | 22818462 | 34 | 822366 | |||
| 2022-04-07 | SC 13D | SCHEDULE 13D | 0000914121-22-002824 | 005-92804 | 22811627 | 34 | 145082 | |||
| 2022-04-06 | 3/A | FORM 3/A | 0001567619-22-008202 | 14894 | ||||||
| 2022-04-01 | 3 | xslF345X02/ownership.xml | 0000902664-22-002394 | 7972 | ||||||
| 2022-04-01 | 4 | FORM 4 SUBMISSION | 0000899243-22-013098 | 6849 | ||||||
| 2022-04-01 | SC 13D | ADAGIO THERAPEUTICS, INC. | 0000902664-22-002385 | 005-92804 | 22795651 | 34 | 88659 | |||
| 2022-03-31 | 10-K | 10-K | 0000950170-22-005112 | 001-40703 | 22789236 | 34 | 18458001 | 1 | 1 | |
| 2022-03-30 | 3 | FORM 3 | 0001567619-22-007732 | 6627 | ||||||
| 2022-03-30 | 3 | FORM 3 | 0001567619-22-007730 | 6643 | ||||||
| 2022-03-30 | 4 | FORM 4 SUBMISSION | 0000899243-22-012866 | 6454 | ||||||
| 2022-03-30 | 4 | FORM 4 SUBMISSION | 0000899243-22-012864 | 11838 | ||||||
| 2022-03-30 | 4 | FORM 4 SUBMISSION | 0000899243-22-012830 | 14294 | ||||||
| 2022-03-30 | 3 | FORM 3 SUBMISSION | 0000899243-22-012829 | 30843 | ||||||
| 2022-03-30 | SC 13D | SC 13D | 0001193125-22-089834 | 005-92804 | 22786749 | 34 | 58991 | |||
| 2022-03-30 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-088649 | 001-40703 | 22783171 | 34 | 255591 | 1 | 1 |
| 2022-03-30 | SC 13D/A | SC 13D/A | 0001193125-22-088640 | 005-92804 | 22783159 | 34 | 213857 | |||
| 2022-03-30 | SC 13D/A | SC 13D/A | 0001193125-22-088618 | 005-92804 | 22783147 | 34 | 111571 | |||
| 2022-03-21 | 8-K | 8-K | 5.02,8.01,9.01 | 0001193125-22-080001 | 001-40703 | 22754171 | 34 | 326227 | 1 | 1 |
| 2022-03-21 | 8-K/A | 8-K/A | 5.02,9.01 | 0001193125-22-079997 | 001-40703 | 22754170 | 34 | 333861 | 1 | 1 |
| 2022-03-01 | 8-K | 8-K | 5.02 | 0001193125-22-061608 | 001-40703 | 22699498 | 34 | 148741 | 1 | 1 |
| 2022-02-23 | 8-K | 8-K | 5.02,8.01,9.01 | 0001193125-22-050174 | 001-40703 | 22664890 | 34 | 177250 | 1 | 1 |
| 2022-02-22 | 8-K | 8-K | 8.01,9.01 | 0001193125-22-047719 | 001-40703 | 22655047 | 34 | 205547 | 1 | 1 |
| 2022-02-18 | 8-K | 8-K | 5.02 | 0001193125-22-046765 | 001-40703 | 22654027 | 34 | 148451 | 1 | 1 |
| 2022-02-14 | SC 13G | SC 13G | 0001193125-22-040725 | 005-92804 | 22628119 | 34 | 199134 | |||
| 2022-02-11 | SC 13G/A | SC 13G/A | 0000905718-22-000207 | 005-92804 | 22620508 | 34 | 47143 | |||
| 2022-02-09 | SC 13G/A | filing.txt | 0000315066-22-000818 | 005-92804 | 22604148 | 34 | 8838 | |||
| 2022-02-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-006030 | 5466 | ||||||
| 2022-02-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-006027 | 5454 | ||||||
| 2022-02-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-006024 | 5455 | ||||||
| 2022-02-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-006022 | 5490 | ||||||
| 2022-02-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-006020 | 5463 | ||||||
| 2022-02-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-006015 | 5454 | ||||||
| 2022-02-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-006011 | 5463 | ||||||
| 2022-01-13 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-22-008197 | 001-40703 | 22527905 | 34 | 184462 | 1 | 1 |
| 2021-12-14 | 8-K | 8-K | 7.01,9.01 | 0001193125-21-356251 | 001-40703 | 211489794 | 34 | 173692 | 1 | 1 |
| 2021-11-29 | 8-K | 8-K | 7.01,9.01 | 0001193125-21-341832 | 001-40703 | 211452974 | 34 | 183359 | 1 | 1 |
| 2021-11-23 | 4 | FORM 4 SUBMISSION | 0001209191-21-066591 | 5427 | ||||||
| 2021-11-23 | 4 | FORM 4 SUBMISSION | 0001209191-21-066581 | 5310 | ||||||
| 2021-11-22 | 3 | FORM 3 SUBMISSION | 0001209191-21-066196 | 6740 | ||||||
| 2021-11-22 | 3 | FORM 3 SUBMISSION | 0001209191-21-066195 | 6962 | ||||||
| 2021-11-22 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-21-336946 | 001-40703 | 211433393 | 34 | 186475 | 1 | 1 |
| 2021-11-16 | 8-K | 8-K | 7.01 | 0001193125-21-331387 | 001-40703 | 211417424 | 34 | 148725 | 1 | 1 |
| 2021-11-15 | 10-Q | 10-Q | 0000950170-21-004586 | 001-40703 | 211410476 | 34 | 9614487 | 1 | 1 | |
| 2021-11-15 | 8-K | 8-K | 2.02,9.01 | 0001193125-21-328992 | 001-40703 | 211406492 | 34 | 286332 | 1 | 1 |
| 2021-11-03 | 3/A | FORM 3/A SUBMISSION | 0001209191-21-062724 | 4630 | ||||||
| 2021-11-02 | 4 | FORM 4 SUBMISSION | 0001209191-21-062491 | 5466 | ||||||
| 2021-11-02 | 3 | FORM 3 SUBMISSION | 0001209191-21-062483 | 8559 | ||||||
| 2021-10-19 | 8-K | 8-K | 8.01,9.01 | 0001193125-21-301964 | 001-40703 | 211330937 | 34 | 173544 | 1 | 1 |
| 2021-10-05 | SC 13G | INITIAL FILING | 0000905718-21-001274 | 005-92804 | 211306748 | 34 | 46868 | |||
| 2021-09-29 | 8-K | 8-K | 8.01,9.01 | 0001193125-21-286813 | 001-40703 | 211292233 | 34 | 184580 | 1 | 1 |
| 2021-09-20 | 10-Q | 10-Q | 0000950170-21-001832 | 001-40703 | 211263503 | 34 | 8838294 | 1 | 1 | |
| 2021-09-20 | 8-K | 8-K | 2.02,9.01 | 0001193125-21-277284 | 001-40703 | 211263303 | 34 | 108804 | ||
| 2021-09-10 | SC 13G | filing.txt | 0000315066-21-001719 | 005-92804 | 211246034 | 34 | 8864 | |||
| 2021-09-10 | 8-K | 8-K | 8.01,9.01 | 0001193125-21-269490 | 001-40703 | 211245879 | 34 | 28205 | ||
| 2021-08-23 | S-8 | S-8 | 0001193125-21-254034 | 333-259008 | 211197411 | 33 | 86963 | |||
| 2021-08-20 | SC 13D | SC 13D | 0001193125-21-252785 | 005-92804 | 211194154 | 34 | 121269 | |||
| 2021-08-20 | SC 13D | SC 13D | 0001193125-21-252773 | 005-92804 | 211194086 | 34 | 246019 | |||
| 2021-08-13 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-004514 | 271704 | ||||||
| 2021-08-12 | 4 | FORM 4 SUBMISSION | 0001209191-21-051299 | 14642 | ||||||
| 2021-08-12 | 4 | FORM 4 SUBMISSION | 0001209191-21-051298 | 19228 |
One latest value per concept from companyfacts (254 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 295.63M | 2026-10-29 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 50.90M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092547 | |
| ffd | NetFeeAmt | NetFeeAmt | USD | 4,939.67 | 2026-05-13 | S-8 | 2026-05-14 | 0001193125-26-223973 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 4,939.67 | 2026-05-13 | S-8 | 2026-05-14 | 0001193125-26-223973 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 35.77M | 2026-05-13 | S-8 | 2026-05-14 | 0001193125-26-223973 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-05-13 | S-8 | 2026-05-14 | 0001193125-26-223973 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 6.37M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | AccountsReceivableGrossCurrent | Accounts Receivable, before Allowance for Credit Loss, Current | USD | 13.90M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092547 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 12.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-20 | 0000950170-25-042332 |
| us-gaap | AccruedEmployeeBenefitsCurrent | Accrued Employee Benefits, Current | USD | 6.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 18.71M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | AccruedLiabilitiesCurrentAndNoncurrent | Accrued Liabilities | USD | 18.71M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | AccruedProfessionalFeesCurrentAndNoncurrent | Accrued Professional Fees | USD | 3.23M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -35,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 1.22B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | AdjustmentForAmortization | Amortization | USD | 280.19M | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-037610 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 2.74M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 8.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables | Allowance for Doubtful Accounts, Premiums and Other Receivables | USD | 49,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | AllowanceForDoubtfulAccountsReceivableCurrent | Accounts Receivable, Allowance for Credit Loss, Current | USD | 100,000 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 48.77M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | Assets | Assets | USD | 183.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 147.85M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | AssetsFairValueAdjustment | Assets, Fair Value Adjustment | USD | 279.92M | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-037610 |
| us-gaap | AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue | Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value | USD | 0 | 2021-12-31 | 2022 | Q2 | 10-Q | 2022-08-15 | 0000950170-22-017242 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 400,000 | 2022-12-31 | 8-K | 2024-02-09 | 0000950170-24-013243 | |||
| us-gaap | BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized | Business Combination, Separately Recognized Transactions, Expenses and Losses Recognized | USD | 7.50M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-31 | 0000950170-22-005112 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 126.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 127.41M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -99.28M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 3.48 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 6.82M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-14 | 0000950170-24-126735 | |
| us-gaap | CommitmentsAndContingencies | Commitments and Contingencies | USD | 0 | 2022-12-31 | 8-K | 2024-02-09 | 0000950170-24-013243 | |||
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 36.89M | 2021-12-31 | 2021 | FY | 10-K | 2022-03-31 | 0000950170-22-005112 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 1.00B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 295.63M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 295.63M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 29,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -119.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | ConvertibleDebt | Convertible Debt | USD | 1.00B | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092547 | |
| us-gaap | ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue | Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-31 | 0000950170-22-005112 | |
| us-gaap | ConvertiblePreferredStockSharesIssuedUponConversion | Convertible Preferred Stock, Shares Issued upon Conversion | shares | 63.24M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-31 | 0000950170-22-005112 | |
| us-gaap | ConvertiblePreferredStockSharesReservedForFutureIssuance | Convertible Preferred Stock, Shares Reserved for Future Issuance | shares | 59.07M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | CostOfGoodsAndServicesSoldDepreciationAndAmortization | Cost, Depreciation and Amortization | USD | 538,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | CostsAndExpenses | Costs and Expenses | USD | 167.11M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | CostsAndExpensesRelatedParty | Costs and Expenses, Related Party | USD | 4.15M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-31 | 0000950170-22-005112 |
| us-gaap | DebtInstrumentBasisSpreadOnVariableRate1 | Debt Instrument, Basis Spread on Variable Rate | pure | 0.003 | 2025-04-18 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | USD | 0 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-15 | 0000950170-22-017242 | |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 719,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092547 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-31 | 0000950170-22-005112 | |
| us-gaap | DeferredRevenue | Deferred Revenue | USD | 1.68M | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-14 | 0000950170-24-096674 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 3.27M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092547 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 252.95M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092547 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 30.93M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092547 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092547 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 719,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092547 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 119.10M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092547 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 1.50M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092547 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 18.87M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092547 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 252.23M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092547 | |
| us-gaap | DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts | Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs | USD | 74.35M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092547 | |
| us-gaap | Depreciation | Depreciation | USD | 382,000 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-14 | 0000950170-24-126735 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.38 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.93 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-13 | 0000950170-22-009799 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.38 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092547 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092547 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.224 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092547 |
| us-gaap | EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount | EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount | USD | 25,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092547 |
| us-gaap | EffectiveIncomeTaxRateReconciliationCrossBorderOtherPercent | EffectiveIncomeTaxRateReconciliationCrossBorderOtherPercent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092547 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | -0.005 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092547 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent | pure | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-31 | 0000950170-22-005112 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.013 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092547 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | -0.002 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092547 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | -0.033 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092547 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | -0.034 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092547 |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | USD | 21.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 12.70M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001193125-25-268076 | |
| us-gaap | FairValueAdjustmentOfWarrants | Fair Value Adjustment of Warrants | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-037610 |
| us-gaap | GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments | Gain (Loss) on Investments, Excluding Other than Temporary Impairments | USD | 0 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-15 | 0000950170-21-004586 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092547 |
| us-gaap | IncomeLossFromContinuingOperationsPerBasicAndDilutedShare | Income (Loss) from Continuing Operations, Per Basic and Diluted Share | USD/shares | -0.93 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-13 | 0000950170-22-009799 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 11.75M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092547 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -11.02M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092547 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 283,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092547 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 682,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092547 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 77,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092547 |
| us-gaap | IncomeTaxReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Amount | USD | 1.80M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092547 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | -7.28M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | -1.73M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | 10,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | 0 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-14 | 0000950170-25-109029 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | 1.68M | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-14 | 0000950170-24-096674 |
| us-gaap | IncreaseDecreaseInInventories | Increase (Decrease) in Inventories | USD | -159,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -707,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | IncreaseDecreaseInOtherCurrentLiabilities | Increase (Decrease) in Other Current Liabilities | USD | 39,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | 97,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentLiabilities | Increase (Decrease) in Other Noncurrent Liabilities | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092547 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 1.55M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | InterestIncomeExpenseNonoperatingNet | Interest Income (Expense), Nonoperating, Net | USD | 4.47M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | InterestReceivable | Interest Receivable | USD | 682,000 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-15 | 0000950170-21-004586 | |
| us-gaap | InterestReceivableCurrent | Interest Receivable, Current | USD | 375,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | InventoryFinishedGoods | Inventory, Finished Goods, Gross | USD | 4.46M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | InventoryNet | Inventory, Net | USD | 25.39M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001193125-25-268076 | |
| us-gaap | InventoryNoncurrent | Inventory, Noncurrent | USD | 25.23M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | InventoryWorkInProcess | Inventory, Work in Process, Gross | USD | 20.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 80,000 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-15 | 0000950170-21-004586 |
| us-gaap | LeaseCost | Lease, Cost | USD | 1.67M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 1.69M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0000950170-22-024516 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 411,000 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0000950170-22-024516 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 328,000 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0000950170-22-024516 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 430,000 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0000950170-22-024516 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 421,000 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0000950170-22-024516 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 102,000 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0000950170-22-024516 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths | Lessor, Operating Lease, Payment to be Received, Year One | USD | 1.40M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-037610 | |
| us-gaap | Liabilities | Liabilities | USD | 33.42M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 183.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 26.81M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | LineOfCreditFacilityCommitmentFeeAmount | Line of Credit Facility, Commitment Fee Amount | USD | 30.00M | 2025-04-18 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | MarketableSecurities | Marketable Securities | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-037610 | |
| us-gaap | MarketableSecuritiesGainLoss | Marketable Securities, Gain (Loss) | USD | 0 | 2022-01-01 | 2022-12-31 | 8-K | 2024-02-09 | 0000950170-24-013243 | ||
| us-gaap | MarketableSecuritiesRealizedGainLoss | Marketable Securities, Realized Gain (Loss) | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-037610 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 19.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -1.82M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -116.83M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -119.26M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 4.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 167.11M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -123.64M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 1.67M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 376,000 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001193125-26-222779 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 1.64M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 6.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 1.12M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 7.64M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 1.26M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 107.80M | 2022-12-31 | 8-K | 2024-02-09 | 0000950170-24-013243 | |||
| us-gaap | OperatingLeasesRentExpenseNet | Operating Leases, Rent Expense, Net | USD | 1.30M | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0000950170-22-024516 |
| us-gaap | OtherAccruedLiabilitiesCurrentAndNoncurrent | Other Accrued Liabilities | USD | 3.78M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 2.37M | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-14 | 0000950170-25-109029 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 707,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent | USD | 6,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | OtherDeferredCompensationArrangementsLiabilityCurrentAndNoncurrent | Other Deferred Compensation Arrangements, Liability, Current and Noncurrent | USD | 0 | 2022-01-01 | 2022 | Q3 | 10-Q | 2022-11-10 | 0000950170-22-024516 | |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 91,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-20 | 0000950170-25-042332 | |
| us-gaap | OtherNoncashIncomeExpense | Other Noncash Income (Expense) | USD | -6,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | OtherNonoperatingGainsLosses | Other Nonoperating Gains (Losses) | USD | 4.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | OtherResearchAndDevelopmentExpense | Other Research and Development Expense | USD | 2.20M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-20 | 0000950170-25-042332 |
| us-gaap | PartnersCapitalAccountPublicSaleOfUnitsNetOfOfferingCosts | Partners' Capital Account, Public Sale of Units Net of Offering Costs | USD | 400.00M | 2022-09-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001193125-25-268076 | |
| us-gaap | PaymentsForRepurchaseOfCommonStock | Payments for Repurchase of Common Stock | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-20 | 0000950170-25-042332 |
| us-gaap | PaymentsForRepurchaseOfInitialPublicOffering | Payments for Repurchase of Initial Public Offering | USD | 231,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-20 | 0000950170-25-042332 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 1.82M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | PreferredStockLiquidationPreferenceValue | Preferred Stock, Liquidation Preference, Value | USD | 505.40M | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-09-20 | 0000950170-21-001832 | |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 9.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | PrepaidExpenseAndOtherAssetsNoncurrent | Prepaid Expense and Other Assets, Noncurrent | USD | 500,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | PrepaidInsurance | Prepaid Insurance | USD | 343,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-349215 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 364,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 0 | 2022-01-01 | 2022-12-31 | 8-K | 2024-02-09 | 0000950170-24-013243 | ||
| us-gaap | ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock | Proceeds from Issuance of Redeemable Convertible Preferred Stock | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-31 | 0000950170-22-005112 |
| us-gaap | ProceedsFromIssuanceOfWarrants | Proceeds from Issuance of Warrants | USD | 17.37M | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-037610 |
| us-gaap | ProceedsFromLicenseFeesReceived | Proceeds from License Fees Received | USD | 200,000 | 2023-06-01 | 2023-06-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0000950170-23-062043 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-20 | 0000950170-25-042332 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 115,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -119.26M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 2.48M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | PurchaseObligation | Purchase Obligation | USD | 12.73M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | PurchaseObligationDueAfterFifthYear | Purchase Obligation, to be Paid, after Year Five | USD | 6.54M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | PurchaseObligationDueInFifthYear | Purchase Obligation, to be Paid, Year Five | USD | 1.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | PurchaseObligationDueInFourthYear | Purchase Obligation, to be Paid, Year Four | USD | 1.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | PurchaseObligationDueInNextTwelveMonths | Purchase Obligation, to be Paid, Year One | USD | 638,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | PurchaseObligationDueInSecondYear | Purchase Obligation, to be Paid, Year Two | USD | 2.55M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | PurchaseObligationDueInThirdYear | Purchase Obligation, to be Paid, Year Three | USD | 919,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear | Purchase Obligation, to be Paid, Remainder of Fiscal Year | USD | 435,000 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0000950170-23-062043 | |
| us-gaap | RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments | Realized Gain (Loss) on Marketable Securities, Cost Method Investments, and Other Investments | USD | 0 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-15 | 0000950170-21-004586 |
| us-gaap | RealizedInvestmentGainsLosses | Realized Investment Gains (Losses) | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-20 | 0000950170-25-042332 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 78.83M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | ResearchAndDevelopmentInProcess | Research and Development in Process | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-31 | 0000950170-22-005112 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 511,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | RestrictedCashCurrent | Restricted Cash, Current | USD | 511,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | RestrictedCashEquivalents | Restricted Cash Equivalents | USD | 1.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -1.07B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | Revenues | Revenues | USD | 43.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability | Right-of-Use Asset Obtained in Exchange for Finance Lease Liability | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-037610 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-037610 |
| us-gaap | RoyaltyExpense | Royalty Expense | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | SaleLeasebackTransactionMonthlyRentalPayments | Sale Leaseback Transaction, Monthly Rental Payments | USD | 1.30M | 2022-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-349215 | |
| us-gaap | SaleOfStockPricePerShare | Sale of Stock, Price Per Share | USD/shares | 8 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0000950170-22-024516 | |
| us-gaap | SellingGeneralAndAdministrativeExpense | Selling, General and Administrative Expense | USD | 84.93M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 8.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding | USD | 300,000 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-13 | 0000950170-22-009799 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | shares | 100,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | USD/shares | 1.15 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | shares | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-037610 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | shares | 1.34M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | USD/shares | 1.54 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised | shares | 124,578 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | shares | 2.69M | 2021-07-31 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 114,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 14.42M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 3.57 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 100,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 3.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 24.02M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 0.83 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 690,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 41.85M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 2.08 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 690,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 41.85M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 2.08 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 0.92 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 1.96 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 1.28 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants | USD | 11.10M | 2025-07-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 150.48M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 | |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 700,000 | 2022-01-01 | 2022-12-31 | 8-K | 2024-02-09 | 0000950170-24-013243 | ||
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 172,223 | 2024-04-01 | 2024-06-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001193125-25-268076 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 504.71M | 2021-01-01 | 2021-12-31 | 8-K | 2024-02-09 | 0000950170-24-013243 | ||
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 109,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 39.06M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092547 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 2,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-20 | 0000950170-25-042332 |
| us-gaap | StockRepurchasedAndRetiredDuringPeriodShares | Stock Repurchased and Retired During Period, Shares | shares | 468,751 | 2021-11-01 | 2021-11-30 | 2021 | FY | 10-K | 2022-03-31 | 0000950170-22-005112 |
| us-gaap | StockRepurchasedDuringPeriodShares | Stock Repurchased During Period, Shares | shares | 5.00M | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0000950170-22-024516 |
| us-gaap | StockRepurchasedDuringPeriodValue | Stock Repurchased During Period, Value | USD | 40.00M | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0000950170-22-024516 |
| us-gaap | SubordinatedBorrowingInterestRate | Subordinated Borrowing, Interest Rate | pure | 0.079 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 169.90M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-31 | 0000950170-22-005112 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 12.65M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-31 | 0000950170-22-005112 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 12.65M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-31 | 0000950170-22-005112 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 12.65M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-31 | 0000950170-22-005112 | |
| us-gaap | TreasuryStockCommonShares | Treasury Stock, Common, Shares | shares | 0 | 2022-12-31 | 8-K | 2024-02-09 | 0000950170-24-013243 | |||
| us-gaap | TreasuryStockShares | Treasury Stock, Shares | shares | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0000950170-23-009516 | |
| us-gaap | TreasuryStockSharesRetired | Treasury Stock, Shares, Retired | shares | 2.62M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0000950170-23-009516 |
| us-gaap | TreasuryStockValue | Treasury Stock, Value | USD | 0 | 2022-12-31 | 8-K | 2024-02-09 | 0000950170-24-013243 | |||
| us-gaap | UnrealizedGainOnSecurities | Unrealized Gain on Securities | USD | 3,000 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-15 | 0000950170-21-004586 |
| us-gaap | UnrealizedLossOnSecurities | Unrealized Loss on Securities | USD | 0 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-15 | 0000950170-21-004586 |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092547 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 7.78M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092547 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 317.56M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 107.87M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-13 | 0000950170-22-009799 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 317.56M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462034 |